| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/07/1996 | CA2198472A1 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle |
| 03/07/1996 | CA2198457A1 Isoxazole derivatives |
| 03/07/1996 | CA2198080A1 Cell cycle regulated repressor and dna element |
| 03/07/1996 | CA2197895A1 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 |
| 03/07/1996 | CA2197566A1 New peptide derivatives with .delta. opioid receptor antagonist or mixed.mu. agonist/.delta. antagonist effects |
| 03/07/1996 | CA2196063A1 Cosolvent parenteral formulation of tirilazad |
| 03/06/1996 | EP0699680A1 Oxazoloquinolinone derivatives, their preparation and their use in therapy |
| 03/06/1996 | EP0699678A1 Crystalline form of dihydro-2,3-benzodiazepine derivative |
| 03/06/1996 | EP0699677A1 Stereoselective process for producing dihydro-2,3-benzodiazepine derivatives |
| 03/06/1996 | EP0699676A1 Physical form of dihidro-2,3-benzodiazepine derivative |
| 03/06/1996 | EP0699675A2 3-(4-(1-Substituted-4-piperazinyl)butyl)-4-thiazolidinone and related compounds |
| 03/06/1996 | EP0699674A1 1-Aryl-2-acetylamidopentanone derivatives for use as tachykinin receptor antagonists |
| 03/06/1996 | EP0699665A1 Imidazoline derivatives, their preparation and their use as tachykinin receptor antagonists |
| 03/06/1996 | EP0699438A2 Use of neurotensin antagonists for the preparation of diuretic drugs |
| 03/06/1996 | EP0699437A1 Pharmaceutical preparations containing polyunsaturated fatty acids, their esters or salts, together with antioxidant vitamins or provitamins |
| 03/06/1996 | EP0699436A1 Controlled release formulation |
| 03/06/1996 | EP0699236A1 Purified mammalian flt3 ligands and agonists and antagonists thereof |
| 03/06/1996 | EP0699199A1 Heteroatom substituted alkyl benzylaminoquinuclidines as substance p antagonists |
| 03/06/1996 | EP0699198A1 New n-benzoylmethyl substituted paroxetine derivatives |
| 03/06/1996 | EP0699197A1 4-p-fluorobenzoyl-1-piperidinyl-propoxy-chromen-4-one derivatives, their preparation and their use in the treatment of psychosis and schizophrenia |
| 03/06/1996 | EP0699195A1 Thioindole pyperidinyl derivatives used as antalgics |
| 03/06/1996 | EP0699186A1 Indole derivatives as antagonists of excitatory amino acids |
| 03/06/1996 | EP0699182A1 Cyclopropylacetonitrile derivatives, preparation thereof and use thereof as drugs |
| 03/06/1996 | EP0699180A1 Bicyclic amide derivatives and their use as muscle relaxants |
| 03/06/1996 | EP0613459B1 N-trityl aspartic acid derivatives for preparing phosphonate nmda antagonists |
| 03/06/1996 | EP0587723B1 Quinuclidine derivatives |
| 03/06/1996 | EP0571471B1 5-heteroyl indole derivatives |
| 03/06/1996 | EP0440670B1 Heterocyclic acetylenic amines having central nervous system activity |
| 03/06/1996 | EP0362259B1 Method of producing cystatin c or modifications hereof and dna-sequence for use when carrying out the method |
| 03/06/1996 | CN1117970A Derivative of 5,6-dihydro-4H-thieno|3,4-c¨ pyrrole, preparation and medical application of same |
| 03/06/1996 | CN1117966A Biphenyl derivatives |
| 03/06/1996 | CN1117960A Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides |
| 03/06/1996 | CN1117874A Nasally administrable compositions |
| 03/06/1996 | CN1117866A Chinese proprietary medicine for caring headache and trigeminal neuralgia |
| 03/05/1996 | US5496826 Pharmaceutical methods of using heterocyclic derivatives of N-phenylamides |
| 03/05/1996 | CA2085733C Polycyclic guanine derivatives |
| 03/05/1996 | CA2010022C Anesthetic oral compositions |
| 03/05/1996 | CA1338121C Anticonvulsant and neuroprotective 2-aminoacetamide derivatives |
| 03/05/1996 | CA1338109C Pyridine derivatives and intermediates thereof |
| 03/03/1996 | CA2156753A1 Heterocyclic derivatives of n-phenylamides |
| 03/02/1996 | CA2157348A1 3-¬4-(1-substituted-4-piperazinyl)butyl|-4-thiazolidinone and related compounds |
| 03/02/1996 | CA2157231A1 Oxa- or thia-aliphatically bridged quinoxaline-2,3-diones |
| 03/01/1996 | CA2156961A1 Use of substituted 4-phenyl-6-amino-nicotinic acid derivatives as medicaments |
| 02/29/1996 | WO1996006098A1 Spiro-azabicyclic compounds useful in therapy |
| 02/29/1996 | WO1996006093A1 7-azabicyclo[2.2.1]-heptane and -heptene derivatives as cholinergic receptor ligands |
| 02/29/1996 | WO1996006091A1 Use of substituted 6-amino-4h-pyrans |
| 02/29/1996 | WO1996006083A1 2-(piperazinyl-1-carbonylmethyl)-1,4-dihydropyridines as bradykinin antagonists |
| 02/29/1996 | WO1996006082A1 Dihydropyridine derivatives as bradykinin antagonists |
| 02/29/1996 | WO1996006081A1 Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydrophenyl)-2-(piperidinyl-1)-alkanol derivatives |
| 02/29/1996 | WO1996006079A1 Biphenylamide derivatives as 5ht1d antagonists |
| 02/29/1996 | WO1996006078A1 N-(2-(pyrrolidinyl-1)-1-phenylethyl)acetamides as kappa receptor antagonists |
| 02/29/1996 | WO1996006077A1 N-[2-(pyrrolidinyl-1)-1-phenylethyl]acetamides as kappa receptor antagonists |
| 02/29/1996 | WO1996005857A1 Device for delivery of substances and methods of use thereof |
| 02/29/1996 | WO1996005837A1 Use of n-substituted phenothiazines |
| 02/29/1996 | WO1996005834A1 Improved pharmaceutical formulations containing ibuprofen and codeine |
| 02/29/1996 | WO1996005828A1 Pyrrolidinyl di-carboxylic acid derivatives as metabotropic glutamate receptor antagonists |
| 02/29/1996 | WO1996005823A1 Methods of inhibiting demyelinating and dysmyelinating diseases |
| 02/29/1996 | WO1996005811A1 Methods for inhibiting neuronal damage |
| 02/29/1996 | DE4430091A1 Verwendung von N-substituierten Phenothiazinen Use of N-substituted phenothiazines |
| 02/29/1996 | DE4429786A1 Verwendung von substituierten 6-Amino-4H-pyranen Pyrans 6-amino-4H-use of substituted |
| 02/29/1996 | CA2198256A1 Use of n-substituted phenothiazines |
| 02/29/1996 | CA2198242A1 Pyrrolidinyl di-carboxylic acid derivatives as metabotropic glutamate receptor antagonists |
| 02/29/1996 | CA2198129A1 Use of substituted 6-amino-4h-pyrans |
| 02/29/1996 | CA2198114A1 Methods of inhibiting demyelinating and dysmyelinating diseases |
| 02/29/1996 | CA2198015A1 Methods of inhibiting neuronal damage |
| 02/29/1996 | CA2196979A1 7-azabicyclo¬2.2.1|-heptane and -heptene derivatives as cholinergic receptor ligands |
| 02/29/1996 | CA2188948A1 Device for delivery of substances and methods of use thereof |
| 02/28/1996 | EP0698597A2 Cyclohexadiene derivatives |
| 02/28/1996 | EP0698391A1 Use of ifenprodil and its diasterisomeren for the preparation of medicaments useful in the treatment of peripheral neuropathies and central neurodegenerative disorders |
| 02/28/1996 | EP0698108A1 Adenoviral vectors of animal origin and use thereof in gene therapy |
| 02/28/1996 | EP0698094A1 Bmp-11 compositions |
| 02/28/1996 | EP0698025A1 Ampa antagonists and a method of treatment therewith |
| 02/28/1996 | EP0698020A1 Pyrimidine derivatives |
| 02/28/1996 | EP0698014A1 3-phenylureido-1,5-benzodiazepine-diones useful as gastrin or cck antagonists |
| 02/28/1996 | EP0697893A1 Neural thread protein gene expression and detection of alzheimer's disease |
| 02/28/1996 | EP0697886A1 New peptide antagonists at glutamate and nmda receptors |
| 02/28/1996 | EP0697873A1 Olefin-substituted long chain compounds |
| 02/28/1996 | EP0697871A1 Treatment process with biologically active tropane derivatives |
| 02/28/1996 | EP0697870A1 Btp receptor modulator of the gaba a?/chloride channel complex for prolonging the duration of the gaba induced membrane current |
| 02/28/1996 | EP0697869A1 Transdermal therapeutic systems for the administration of serotonin agonists |
| 02/28/1996 | EP0697864A1 Treatment of septic shock |
| 02/28/1996 | EP0697859A1 Stable, ingestable and absorbable nadh and nadph therapeutic compositions |
| 02/28/1996 | EP0547224B1 14-O-p-CHLOROBENZOYLACONINE AND ANALGESIC/ANTIINFLAMMATORY AGENT |
| 02/28/1996 | EP0494978B1 Heterocyclic compounds |
| 02/28/1996 | CN1117733A Silylated acetylcholinesterase inhibitors |
| 02/28/1996 | CN1117731A Heteroaromatic compounds with antipsychotic activity |
| 02/28/1996 | CN1117493A Azaaliphatatially bridged quinoxaline-2,3-diones |
| 02/28/1996 | CN1117484A Fatty acid derivatives |
| 02/27/1996 | US5494934 Antidepressants, hypotensive agents |
| 02/27/1996 | US5494928 Indole derivatives |
| 02/27/1996 | US5494917 Cognition enhancing quinuclidine compound |
| 02/27/1996 | US5494915 Isoindolinone derivative, preparation thereof, and pharmaceutical compositions containing same |
| 02/27/1996 | US5494910 Benzofuran derivatives as 5-HT1 -like receptor antagonists |
| 02/27/1996 | US5494909 Antiischemic agents |
| 02/27/1996 | US5494907 11-β substituted-19-nor steroids |
| 02/27/1996 | US5494894 Using a pentapeptide |
| 02/27/1996 | CA2155447A1 Substituted biphenyl isoxazole sulfonamides |
| 02/27/1996 | CA2030204C Pharmaceutical compositions of tebufelone |
| 02/27/1996 | CA1338089C Sulfonic acid esters |
| 02/26/1996 | CA2156788A1 Use of 6-amino-1,4-dihydropyridines as medicaments for treatment of the central nervous system, and processes for their preparation |